Publicacións en colaboración con investigadores/as de Hospital de Sant Pau i Santa Tecla (11)

2018

  1. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study

    Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82

2017

  1. Contact sensitization to limonene and linalool hydroperoxides in Spain: a GEIDAC* prospective study

    Contact Dermatitis, Vol. 76, Núm. 2, pp. 74-80

  2. Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

    British Journal of Haematology, Vol. 178, Núm. 5, pp. 699-708

2015

  1. Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: The RELAX study

    HIV Medicine, Vol. 16, Núm. 10, pp. 628-634

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2013

  1. Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

    PLoS ONE, Vol. 8, Núm. 9

  2. Spironolactone in mild chronic heart failure: Insights from a propensity-matched analysis of the MUSIC study cohort

    International Journal of Cardiology, Vol. 168, Núm. 4, pp. 4525-4527

2011

  1. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: Previously identified variants and mucins

    BMC Cancer, Vol. 11

2010

  1. El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infeccin por VIH-1

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 9, pp. 615-620

2008

  1. Association of Blood Pressure and Its Evolving Changes With the Survival of Patients With Heart Failure

    Journal of Cardiac Failure, Vol. 14, Núm. 7, pp. 561-568

2006

  1. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir

    AIDS, Vol. 20, Núm. 10, pp. 1407-1414